4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025499
CHIEF MEDICAL OFFICER sold 816 shares at $30.00 ($24,482)
- CHIEF MEDICAL OFFICER acquired 816 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Collins Helen Louise · CHIEF MEDICAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +816 | $2.48 | $2,024 | 816 | D |
| 2024-10-18 | Sale : show line 2 in the form 10b5-1 | −816 | $30.00 | $24,482 | 0 | D |
| Open-market sales · 816 sh · avg $30.00 · $24,482 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-18 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −816 | 266,268 | D |
Loading xslF345X05/form4-10222024_081038.xml…